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Abstract
Background: There is evidence that in cirrhotic patients, certain hemodynamic parameters, such as blood pressure
and heart rate, are related to the severity of liver disease. This study investigated whether non-invasive 24-hour
ambulatory blood pressure and heart rate are more closely associated with markers of liver disease severity than
conventional office measurements.
Methods: Ambulatory patients with cirrhosis underwent office blood pressure and heart rate measurements,
24-hour ambulatory blood pressure monitoring and blood laboratory tests.
Results: Fifty-one patients (32 men, mean age 57.4 ± 11.3 years) completed the study. Twenty six patients had
compensated liver cirrhosis (group A) and 25 patients had more advanced liver disease (group B). Group A and B
patients differed significantly both in ambulatory asleep diastolic blood pressure (p < 0.05) and office diastolic
blood pressure (p < 0.01), which were lower in more advanced liver disease. Office blood pressure and heart rate
correlations were similar to or even stronger than ambulatory ones. Ambulatory blood pressure and heart rate
awake-asleep variation (dipping) showed a relatively flat pattern as markers of liver dysfunction were deteriorating.
The strongest correlations were found with both ambulatory and office heart rate, which increased as indicators of
severity of liver disease were worsening.
Conclusions: Heart rate seems to be a more reliable marker of ongoing liver dysfunction than blood pressure.
Evaluation of blood pressure and heart rate with 24-hour ambulatory measurement does not seem to offer more
information than conventional office measurements.
Background
Hepatic cirrhosis is accompanied by alterations of sys-
temic circulation, such as reduced peripheral vascular
resistance, low or low-normal blood pressure (BP) and
increased heart rate (HR), stroke volume and cardiac
output at rest, a situation which is called “hyperdynamic
circulation”. These alterations deteriorate further with
the aggravation of hepatocellular failure [1-5]. It has
been shown that these changes are associated with over-
all survival of cirrhotic patients [6,7]. Reduced vascular
resistance in cirrhotic patients has been attributed to
several circulating vasodilators [8-15]. Peripheral
vasodilatation in cirrhosis leads to reduced “effective”
arterial blood volume and activation of counteracting
vasoconstrictor systems such as renin-angiotensin-
aldosterone system, sympathetic nervous system and
hypothalamic-pituitary system (vasopressin secretion)
[3]. Consequently, urine water and sodium excretion is
reduced and total blood volume is expanded.
Only two published trials have compared non-invasive
24-hour ambulatory blood pressure (ABP) parameters of
cirrhotic patients with those of healthy controls and
investigated their correlation with markers of severity of
liver disease [16,17]. It has been suggested that 24-hour
ABP monitoring, compared with conventional office BP
measurements, has higher reproducibility and stronger
correlation with target organ damage and total cardio-
vascular risk in hypertensive patients [18-25]. We
hypothesized that, as long as office BP and HR are
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ment of the BP profile, as provided by 24-hour ABP
measurement, would be proved a reliable index of liver
dysfunction.
In this study, ambulatory cirrhotic patients underwent
24-hour ABP monitoring, as well as routine office BP
and HR measurements. Additionally, biochemical and
hormonal markers of liver function were tested. Patients
were divided into two groups, those with Child A
(group A) and those with Child B and C liver disease
(group B). BP and HR parameters were compared
between the two groups and statistical correlations
between those parameters and aforementioned markers
of liver function and portal hypertension were studied,
in order to assess whether non-invasive 24-hour mea-
surements are more closely associated with markers of
liver disease severity than the conventional office
measurements.
Methods
Subjects
This cross-sectional study included ambulatory patients
with liver cirrhosis irrespective of aetiology, sex or age (>
18 years). Patients with known history of arterial hyper-
tension, treated or untreated, heart failure, cardiac
cirrhosis, bedridden, with clinical signs of hepatic ence-
phalopathy, active infection or hemorrhage within the
last 4 weeks before the study, active alcohol consumption
or symptoms of withdrawal and patients with serum
creatinine >133 μmol/L or serum Na <130 mmol/L on
two consecutive occasions, were excluded. Twenty six
patients with Child A cirrhosis formed the group A.
Twenty one Child B and 4 Child C patients formed the
group B. The latter 4 patients were borderline for Child
C. All subjects gave written informed consent before
undergoing the procedures of the study. The study proto-
col was approved by Local Ethics Committee.
General information
S t u d yp r o c e d u r e sw e r ep e r f o r m e da taD a yC l i n i co fa
University Hospital. All participants gave routine medi-
cal history and underwent physical examination. The
following characteristics were recorded for each subject:
age, sex, body height and weight, history of diabetes
mellitus, smoking habits (smokers, ex-smokers, non-
smokers), concomitant medical treatment, peripheral
oedema or ascites, confirmed by physical examination
or recent imaging examination and aetiology of cirrho-
sis. Child score and MELD score [26] were calculated.
Diuretics, b-blockers or other drugs affecting BP, when
used, were stopped 7 days before and during the study.
No specific instructions for salt intake were given. Ten
of the patients included in the study were treated with
b-blockers. The indication of b-blockers was first
variceal bleeding prophylaxis. All participants who
stopped temporarily b-blockers had low risk of variceal
bleeding (grade A esophageal varices and no history of
variceal bleeding). B-blockers were withdrawn for 8 days
(7 days wash-out plus one day for the study procedures).
The consultant hepatologists (S.P.D and A.A) considered
that there was no additional risk for the above patients
from 8-day b-blocker withdrawal. To demonstrate the
safety of this procedure, information about mortality
and morbidity, including variceal bleeding and hospital
admission due to liver disease, was retrospectively
reviewed for all participants 12 months after their inclu-
sion into the study. This information was obtained from
outpatient clinic files or by telephone contact.
Office BP and HR measurements
Office BP and HR were measured on two consecutive
morning visits, by physicians trained according to the
British Hypertension Society Protocol, using a mercury
sphygmomanometer [27]. Measurements were per-
formed on the left arm, with the subject sitting for at
least 5 min. Cuffs with inflatable bladders encircling
>80% of the arm circumference of each individual, were
used. The 1
st Korotkoff sound was recorded as systolic
blood pressure (SBP) and the 5
th as diastolic blood pres-
sure (DBP). Three measurements were taken for each
subject with one min interval. HR was measured once
after the 1
st BP measurement, with palpation of the
radial pulse for 30 sec.
Ambulatory BP and HR measurements
Ambulatory BP and HR were monitored for 24 hours,
on a routine working day, using validated oscillometric
devices Spacelabs 90207 or 90217 (Spacelabs Inc, Red-
mond, WA, USA, with bladder size 23 × 12 cm or 30 ×
14 cm, where appropriate) [28]. Measurements were
taken at 20-min intervals during the whole 24-hour per-
iod. Patients were instructed to follow their usual daily
activities, but to remain still with their forearm extended
during each BP reading and to keep a brief timetable of
the hours they stayed in bed. ABP measurements with
<20 valid readings during the day and/or <10 during the
night had to be repeated. The accuracy of each ABP
device was tested before applying to each subject against
a mercury column (Y-connection). Three successive
measurements were made, in order to ensure that the
difference between oscillometric and stethoscopic read-
ing was not >10 mmHg in all 3 SBP or DBP readings.
In that case the device was substituted by another one
and tested again.
Laboratory tests
Blood samples for international normalized ratio (INR),
total bilirubin, alanine and aspartate aminotransferases
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aldosterone were taken with the subject sitting on a
chair for at least 10 min, fasting for 8 to 12 hours and
after he/she had been awake and active for at least one
hour. Samples were drawn either on the 1
st day of the
study, after medical history was obtained, physical exam-
ination was performed and office BP measurements
were made and before applying the ABP device, or on
the 2
nd day, after withdrawing the ABP device and per-
forming the office BP measurements. Renin and aldos-
terone concentration was measured after serum
specimens were centrifuged and frozen at below -20°C
for <6 months. Routine laboratory methods were used
for INR and biochemistry tests. Serum renin and aldos-
terone concentration was measured with Nichols
Advantage® Direct Renin and Nichols Advantage® Aldos-
terone chemiluminescense methods (normal values in
u p r i g h tp o s i t i o n3 . 3 - 4 1μIU/ml for renin and 3-34 ng/dl
for aldosterone).
Statistical Analysis
For each office visit average sitting SBP, DBP and HR
were included in the analysis. Ambulatory SBP, DBP
and HR readings were averaged to 24-hour, awake and
asleep values, according to each individual subject’s
sleeping hours. Logarithmic transformation was per-
formed in not normally distributed data (total bilirubin,
ALT, AST, renin and aldosterone). T-tests were used to
evaluate the difference of the mean of quantitative vari-
ables among two groups. X
2 test was used to evaluate
frequency differences of qualitative variables among two
groups. Statistical correlations of office and ambulatory
BP and HR measurements with each of the following
markers, i.e. Child score, MELD score, total bilirubin,
albumin, INR, ALT, AST, renin and aldosterone, were
studied and Pearson correlation coefficients were calcu-
lated. Quantitative variables are presented as mean ±
SD. Statistical software MINITAB INC (release 13.31,
State College, Pennsylvania, USA) was used for all statis-
tical procedures. A p value of < 0.05 was considered sta-
tistically significant.
Results
Patients’ characteristics
From November 2003 until May 2006 60 consecutive
patients were recruited. Five refused to participate, 3
were excluded due to history of hypertension, and one
due to poor general condition (not fully ambulatory).
Fifty-one patients completed the study, (32 men), with
mean age 57.4 ± 11.3 (SD) years. The cause of cirrhosis
was alcohol abuse, viral hepatitis and miscellaneous in
23, 20 and 8 patients respectively. Twenty six, 21 and 4
patients were Child A, B and C respectively. Child
B and C patients were analyzed together (group B).
Mean Child score was 6.7 in all patients, 5.3 in group A
a n d8 . 2i ng r o u pB .M e a nM E L Ds c o r ew a s1 1 . 7 ,8 . 9a n d
14.7, respectively. Demographic data and other character-
istics of the participants are presented in Table 1.
Comparison of office and ambulatory BP and HR
parameters between group A and group B patients
Ambulatory and office BP and HR values are presented
in Table 2. The only statistically significant difference
between group A and group B was in ambulatory asleep
DBP (p < 0.05) and in office DBP. As expected, estab-
lished markers of liver function (total serum bilirubin,
I N R ,s e r u ma l b u m i n )d i f f e r e ds i g n i f i c a n t l yb e t w e e nt h e
two groups (Table 1).
Correlations between office and ambulatory blood
pressure and laboratory markers
The relationship between office and ambulatory BP and
laboratory biochemical and hormonal markers is
Table 1 Characteristics of study population according to
the severity of liver disease
Group A Group B All p
N 26 25 51
Male (%) 50 76 63 0.05
Age (years) 56.7 ±
13.0
58.1 ± 9.4 57.4 ± 11.3 NS
BMI (kg/m
2) 25.9 ± 3.8 27.2 ± 4.8 26.5 ± 4.3 NS
Diabetes (%) 11.5 8 9.8 NS
Active smokers (%) 38.5 52 45.1 NS
Alcoholic cirrhosis (%) 30.8 60 45.1 < 0.05
Hepatitis B (%) 26.9 16 21.6 NS
Hepatitis C (%) 23.1 12 17.6 NS
PBC (%) 11.5 0 5.9 NS
Autoimmune
hepatitis(%)
3.8 4 3.9 NS
Steatohepatitis (%) 3.8 4 3.9 NS
Cryptogenic
cirrhosis(%)
04 2 N S
Ascites (%) 0 52 25.5 <0.001
Peripheral oedema
(%)
0 12 5.9 NS
Total bilirubin
(μmol/L)
18.8 ± 8.5 51.3 ± 47.9 34.2 ± 37.6 <0.001
Albumin (g/L) 40.0 ± 5.0 33.0 ± 4.0 37.0 ± 5.0 <0.001
INR 1.2 ± 0.1 1.5 ± 0.3 1.3 ± 0.3 <0.001
ALT (IU/l) 44.5 ±
34.7
55.6 ± 56.4 49.9 ± 46.5 NS
AST (IU/l) 52.7 ±
38.4
84.3 ± 69.3 68.2 ± 57.4 < 0.01
Renin (μIU/ml) 27.5 ±
29.7
90.3 ±
161.9
57.7 ±
117.3
NS
Aldosterone (ng/dl) 11.7 ±
10.1
41.9 ± 85.2 26.2 ± 60.8 NS
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lated negatively with serum renin. 24-hour and asleep
ambulatory SBP gave no significant correlations, either
with Child and MELD scores, or with laboratory para-
meters. On the other hand, office SBP measurements
showed stronger correlations, negative with Child score,
INR, serum renin and aldosterone concentration and
positive with serum albumin. Statistically significant
positive correlations were found between ambulatory
DBP (24-hour, awake and asleep) and serum albumin.
Office DBP measurements on the other hand, showed
stronger correlations, negative with Child and MELD
scores, total serum bilirubin and INR and positive with
serum albumin.
Correlations between office and ambulatory HR and
laboratory parameters
Both office and ambulatory HR measurements showed
stronger correlations than BP parameters, positive with
Child and MELD scores, total serum bilirubin, INR,
renin and aldosterone and negative with serum albumin
(Table 4). Correlations between serum albumin and BP
and HR measurements in the office (visit 1) and with
24-hour ambulatory monitoring are presented as scatter
plots in Figure 1.
BP and HR “dipping” and laboratory parameters
Awake-asleep differences in ambulatory measurements
(dipping) revealed a few correlations with laboratory
parameters. Correlations were negative between SBP
dipping, renin and aldosterone concentration (-0.33 and
-0.35, p < 0.05 respectively), negative between DBP dip-
ping and aldosterone concentration (-0.32, p < 0.05),
positive between HR dipping and albumin concentration
(0.35, p < 0.05) and negative between HR dipping and
Child score (-0.22, p < 0.05). Comparisons between
group A and group B regarding BP and HR awake-
asleep dipping revealed contradictory and not statisti-
cally significant differences (Table 2).
Retrospective assessment of patients’ health status 12
months after their participation into the study revealed
Table 2 Comparison of office and ambulatory blood
pressure (mmHg) and heart rate (beats per min) in group
A versus group B patients
Group A Group B All p
Office
Visit 1
SBP 134.9 ±
17.4
127.4 ±
16.7
131.2 ±
17.3
NS
DBP 81.9 ±
11.3
73.8 ± 7.6 77.9 ±
10.4
<0.01
HR 72.7 ±
11.6
74.4 ±
10.6
73.5 ±
11.1
NS
Office
Visit 2
SBP 130.6 ±
16.8
125.3 ±
15.0
128.0 ±
16.0
NS
DBP 79.8 ±
10.5
72.5 ± 8.5 76.1 ±
10.2
0.01
HR 73.8 ±
10.1
78.4 ±
13.6
76.1 ±
12.1
NS
24-hour ambulatory SBP 121.3 ±
14.3
121.7 ±
10.1
121.5 ±
12.3
NS
DBP 72.9 ± 8.8 69.6 ± 5.4 71.3 ± 7.4 NS
HR 73.8 ±
10.7
77.3 ±
10.6
75.5 ±
10.7
NS
Awake ambulatory SBP 127.1 ±
14.1
128.4 ±
12.2
127.7 ±
13.0
NS
DBP 77.8 ± 8.7 74.6 ± 5.2 76.2 ± 7.3 NS
HR 78.1 ±
11.0
79.9 ±
10.6
79.0 ±
10.7
NS
Asleep ambulatory SBP 114.0 ±
14.9
111.5 ±
10.0
112.8 ±
12.7
NS
DBP 66.8 ± 9.7 61.8 ± 7.0 64.4 ± 8.8 <0.05
HR 68.0 ±
12.0
72.8 ±
10.7
70.3 ±
11.6
NS
Awake-asleep
difference
SBP 13.1 ± 6.1 17.0 ± 8.9 15.0 ± 7.8 NS
DBP 11.0 ± 4.7 12.8 ± 6.0 11.9 ± 5.4 NS
HR 10.1 ± 7.6 7.1 ± 5.8 8.6 ± 6.9 NS
SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate
Table 3 Correlations of office and ambulatory blood pressure with clinical and laboratory markers of liver disease
Office SBP/DBP
Visit 1
Office SBP/DBP
Visit 2
24-hour ambulatory
SBP/DBP
Awake ambulatory
SBP/DBP
Asleep ambulatory
SBP/DBP
Child score -0.33*/-0.39** -0.25/-0.36** -0.04/-0.17 -0.05/-0.21 -0.05/-0.15
MELD score -0.25/-0.30* -0.20/-0.29* 0.03/-0.06 0.01/-0.09 0.02/-0.06
T. Bilirubin -0.18/-0.28* -0.11/-0.26 0.09/-0.04 0.10/-0.05 0.04/-0.06
Albumin 0.34 */0.51*** 0.21/0.44*** 0.07/0.33** 0.07/0.38** 0.11/0.32*
INR -0.24/-0.23 -0.31*/-0.30* -0.03/-0.07 -0.03/-0.08 -0.05/-0.08
ALT -0.04/-0.16 -0.13/-0.13 -0.17/-0.19 -0.13/-0.16 -0.20/-0.21
AST -0.03/-0.23 -0.08/-0.21 -0.08/-0.20 -0.03/-0.18 -0.16/-0.25
Renin -0.36**/-0.09 -0.29*/-0.07 -0.21/0.03 -0.30*/-0.05 -0.11/0.09
Aldosterone -0.30*/-0.12 -0.25/-0.08 -0.07/0.10 -0.16/-0.01 0.05/0.19
(Correlation coefficients r)
SBP, systolic blood pressure; DBP, diastolic blood pressure;
*, p < 0.05; **, p < 0.01; ***, p < 0.001
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was lost to follow-up). Two patients have died, one
due to hepatocellular carcinoma and another due to
progressive liver failure. None of the abovementioned
3 patients was on b-blocker therapy before the study.
The rest 48 patients were alive one year after study
inclusion, with no further complications related to
liver disease.
Discussion
This is the first study that evaluated the 24-hour BP and
HR profile in relation to markers of liver function in
patients with cirrhosis in fully ambulatory conditions.
Two previous studies have assessed the ABP profile in
patients with alcoholic cirrhosis, of whom about half
were at Child C stage. Both of these studies have been
conducted in hospitalized patients and continued
Table 4 Correlations of office and ambulatory heart rate with clinical and laboratory markers of liver disease
Office HR
Visit 1
Office HR
Visit 2
24-hour ambulatory HR Awake ambulatory HR Asleep ambulatory HR
Child score 0.27 0.43** 0.32* 0.24 0.35*
MELD score 0.32* 0.40** 0.36** 0.28* 0.40**
T. Bilirubin 0.34* 0.40** 0.35** 0.28* 0.40**
Albumin - 0.29* - 0.44*** - 0.36** -0.25 - 0.45***
INR 0.31* 0.35* 0.36** 0.31* 0.33**
ALT 0.10 0.09 0.01 0.02 0
AST 0.18 0.21 0.17 0.14 0.20
Renin 0.35* 0.56*** 0.49*** 0.48*** 0.43**
Aldosterone 0.41** 0.48*** 0.44*** 0.40** 0.44***
(Correlation coefficients r)
HR, heart rate; *, p < 0.05; **, p < 0.01; ***, p < 0.001
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Figure 1 Correlations between serum albumin and blood pressure (BP) and heart rate measurements in the office (visit 1) and with
24-hour ambulatory monitoring.
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Page 5 of 8diuretic treatment, which have probably influenced the
study findings. These studies showed that ABP is lower
in patients than in controls, especially during the day.
Awake and asleep HR was higher in cirrhotic patients
and awake-asleep variation was lower than in controls.
BP and HR parameters correlated with indices of liver
function. Among cirrhotic patients, only the difference
in DBP between Child A and C reached statistical signif-
icance [16,17].
This study included cirrhotic, non-hospitalized,
patients, of whom only 4 marginally fulfilled Child stage
C criteria. Therefore, the differences in BP and HR
between study groups had to be striking, in order to be
revealed. This study intended to investigate the relation-
ship of the 24-hour ambulatory BP and HR with
markers of liver dysfunction. Therefore, only fully ambu-
latory patients were included in whom a few days with-
drawal of drug treatment (diuretics and b-blockers) was
acceptable. On the other hand, severely diseased patients
in whom the diurnal variation of these hemodynamic
parameters was distorted due to limited physical activity,
which is outside the standards of ABP monitoring [25]
and in whom drug treatment could not be withdrawn,
were excluded.
A consistent relationship between both the degree of
BP reduction and tachycardia and the severity of hepatic
dysfunction was shown in the present study. These find-
ings are in line with previous observations showing that
BP is reduced and HR was elevated in advanced liver
disease [1-5]. DBP in both office visits and asleep ambu-
latory DBP were significantly lower in the group with
more advanced liver disease. HR did not differ signifi-
cantly between group A and B patients (Table 2). It is
worth noting though, that among all hemodynamic
parameters, HR exhibited the strongest association with
markers of liver disease severity (Tables 3 and 4).
Because the sample size is relatively small, the main
analysis was performed by treating the data as continu-
ous rather than categorical variables, which allows the
assessment of associations. The correlation factors are
relatively low and according to the r
2 value for the asso-
ciation between HR of office visit 2 and serum renin,
only 31% of the variation of HR could be explained by
the renin variation (Table 4). Attempting to explain the
finding that HR was more closely related to markers of
liver function than other hemodynamic parameters, we
presume that homeostatic mechanisms, such as renin-
angiotensin-aldosterone system and sympathetic nervous
system, counteracting the reduction of effective arterial
blood volume in cirrhotic patients, attempt to “correct”
BP towards normal levels, in the expense of HR eleva-
tion [29-31]. Another assumption could be that elevated
cardiac output, which has been observed in cirrhotic
patients, is achieved more effectively through elevation
of HR and less through elevation of stroke volume,
because of the compromised capacity of the left ventri-
cle to raise stroke volume (cirrhotic cardiomyopathy)
[32-34]. It is noteworthy that serum albumin is related
with all hemodynamic parameters studied (Tables 3 and
4) suggesting that, apart from peripheral vasodilatation,
plasma oncotic pressure reduction remains an important
determinant of hyperdynamic circulation in cirrhosis.
Although 24-hour ambulatory values are considered
more reliable than office measurements in the evalua-
tion of BP and HR in hypertensive patients, this does
n o ts e e mt ob et h ec a s ei nt h es e t t i n go fc i r r h o t i c
patients [18-25]. Indeed, the effect of differences in day-
time activity during 24 h ambulatory monitoring is off-
set by the larger number of readings and the fact that
these are taken in routine daily conditions, resulting
thereby to superior reproducibility of ambulatory com-
pared to office BP measurements. We hypothesized that
because hemodynamic parameters such as low office BP
and increased HR are related to the severity of liver
damage, a detailed evaluation of the BP profile, as pro-
vided by 24-hour ambulatory BP measurement, would
be proved a more reliable index of liver dysfunction
than the conventional hemodynamic assessment (office
BP and HR). The unexpected finding that office mea-
surements were not inferior to ambulatory measure-
ments, could be attributed to the meticulous and
according to relevant guidelines procedure of office BP
and HR measurements, in the setting of a hypertension
research unit. Even if 24-hour ABP is proved accurate
and valuable in hypertensive patients [18-25], its useful-
ness in the population of cirrhotic patients is therefore
not well documented.
Another interesting finding is the reduced awake-
asleep variation of BP and HR in patients with more
severe portal hypertension, as suggested by higher renin
and aldosterone levels. Reduced awake-asleep variation
of BP and HR has also been demonstrated in patients
with more severe hepatocellular dysfunction, as sug-
gested by lower albumin levels. The presence of reduced
awake-asleep variation in more advanced liver disease
has also been reported by previous studies [16,17,35,36].
Since a major determinant of awake-asleep variation of
BP and HR is physical activity [37], it could be hypothe-
sized that cirrhotic patients have less physical activity
than normal subjects, even though patients in a poor
condition have been excluded in this study. Reduced
awake-asleep variation of BP and HR might also be
attributed to impaired autonomic nervous activity,
which has been reported in cirrhotic patients [38-40],
leading to vascular hyporeactivity. Cirrhotic patients
have been reported to exhibit an almost unaltered car-
diac output and a small alteration in vascular resistance
from daytime to nighttime [16,17]. These findings are
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cirrhosis, comprising a blunt response to stimuli that
normally influence circulation [32-34]. A limitation of
the present study concerning this point is that alcoholic
cirrhosis was significantly more frequent among group B
patients (Table 1).
This was a cross-sectional study investigating associa-
tions and was not designed to assess hard end-points.
Moreover, the study sample is too small to allow con-
clusions in relation to outcome. Further research is
needed, in order to investigate the association between
hemodynamic parameters and hard endpoints such as
survival and hospitalization.
Conclusions
This study showed that HR, measured either with ABP
monitoring or conventional office measurement, seems
to be a more reliable marker of ongoing liver dysfunc-
tion than BP. Given that normally the range of HR is
wide, it is not possible to define a threshold that might
indicate severe liver insufficiency. An abnormal pattern
of 24-hour BP and HR daily variation was observed
probably due to lack of regulation of the aforementioned
hemodynamic parameters from daytime to nighttime.
This abnormal diurnal pattern was evident in advanced
liver disease. In conclusion, these data do not support
the use of 24-hour ambulatory BP and HR as a more
accurate method than office measurements for the eva-
luation of the severity of liver insufficiency.
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